FI952203A - Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi - Google Patents

Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi Download PDF

Info

Publication number
FI952203A
FI952203A FI952203A FI952203A FI952203A FI 952203 A FI952203 A FI 952203A FI 952203 A FI952203 A FI 952203A FI 952203 A FI952203 A FI 952203A FI 952203 A FI952203 A FI 952203A
Authority
FI
Finland
Prior art keywords
diseases
compounds
preparation
treatment
cyclohexane derivatives
Prior art date
Application number
FI952203A
Other languages
English (en)
Swedish (sv)
Other versions
FI952203A0 (fi
FI110097B (fi
Inventor
Horst Hemmerle
Gerrit Schubert
Hans-Joerg Burger
Andreas Herling
Suad Efendic
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI952203A0 publication Critical patent/FI952203A0/fi
Publication of FI952203A publication Critical patent/FI952203A/fi
Application granted granted Critical
Publication of FI110097B publication Critical patent/FI110097B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI952203A 1994-05-10 1995-05-08 5-(3-imidatso[4,5-b]pyridin-1-yyli-3-fenyyli-akryloyylioksi)-sykloheksaanikarboksyylihappojohdannaiset, niiden käyttö ja yhdisteitä sisältävät lääkeaineet FI110097B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4416433A DE4416433A1 (de) 1994-05-10 1994-05-10 Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten
DE4416433 1994-05-10

Publications (3)

Publication Number Publication Date
FI952203A0 FI952203A0 (fi) 1995-05-08
FI952203A true FI952203A (fi) 1995-11-11
FI110097B FI110097B (fi) 2002-11-29

Family

ID=6517746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952203A FI110097B (fi) 1994-05-10 1995-05-08 5-(3-imidatso[4,5-b]pyridin-1-yyli-3-fenyyli-akryloyylioksi)-sykloheksaanikarboksyylihappojohdannaiset, niiden käyttö ja yhdisteitä sisältävät lääkeaineet

Country Status (23)

Country Link
US (1) US5739147A (fi)
EP (1) EP0682024B1 (fi)
JP (1) JP3790564B2 (fi)
KR (1) KR100355690B1 (fi)
CN (1) CN1043643C (fi)
AT (1) ATE187454T1 (fi)
AU (1) AU683148B2 (fi)
CA (1) CA2149007C (fi)
CZ (1) CZ288443B6 (fi)
DE (2) DE4416433A1 (fi)
DK (1) DK0682024T3 (fi)
ES (1) ES2141276T3 (fi)
FI (1) FI110097B (fi)
GR (1) GR3032519T3 (fi)
HK (1) HK1011989A1 (fi)
HU (1) HU220865B1 (fi)
NO (1) NO304314B1 (fi)
NZ (1) NZ272082A (fi)
PL (1) PL180074B1 (fi)
RU (1) RU2140416C1 (fi)
TW (1) TW421648B (fi)
UA (1) UA41340C2 (fi)
ZA (1) ZA953726B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
PT1248604E (pt) 2000-01-21 2007-01-31 Novartis Ag Associações compreendendo inibidor de dipeptidilpeptidase-iv
US20040143015A1 (en) * 2001-03-12 2004-07-22 Villhauer Edwin Bernard Combination of organic compounds
ES2445180T5 (es) 2005-09-14 2022-02-01 Takeda Pharmaceuticals Co Administración de inhibidores de dipeptidil peptidasa
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
ES2445917T3 (es) 2010-02-03 2014-03-06 Takeda Pharmaceutical Company Limited Inhibidores de quinasa 1 reguladora de la señal de apoptosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
TW255880B (fi) * 1992-09-09 1995-09-01 Hoechst Ag
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
DE4408082A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE4413402A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Herstellung von Zwischenprodukten für die Synthese von Glucose-6-Phosphatase-Inhibitoren sowie neue Zwischenprodukte

Also Published As

Publication number Publication date
ES2141276T3 (es) 2000-03-16
AU1792395A (en) 1995-11-16
CZ288443B6 (en) 2001-06-13
JP3790564B2 (ja) 2006-06-28
AU683148B2 (en) 1997-10-30
GR3032519T3 (en) 2000-05-31
UA41340C2 (uk) 2001-09-17
KR950032191A (ko) 1995-12-20
DK0682024T3 (da) 2000-05-22
ATE187454T1 (de) 1999-12-15
PL180074B1 (pl) 2000-12-29
RU2140416C1 (ru) 1999-10-27
FI952203A0 (fi) 1995-05-08
RU95107147A (ru) 1997-03-20
NZ272082A (en) 1996-09-25
ZA953726B (en) 1996-01-11
FI110097B (fi) 2002-11-29
HK1011989A1 (en) 1999-07-23
PL308521A1 (en) 1995-11-13
HU220865B1 (en) 2002-06-29
JPH07330767A (ja) 1995-12-19
NO304314B1 (no) 1998-11-30
HUT71797A (en) 1996-02-28
DE4416433A1 (de) 1995-11-16
EP0682024A1 (de) 1995-11-15
CA2149007A1 (en) 1995-11-11
CA2149007C (en) 2005-07-26
CN1118782A (zh) 1996-03-20
TW421648B (en) 2001-02-11
KR100355690B1 (ko) 2002-12-26
CZ119595A3 (en) 1995-12-13
EP0682024B1 (de) 1999-12-08
NO951820L (no) 1995-11-13
NO951820D0 (no) 1995-05-09
US5739147A (en) 1998-04-14
CN1043643C (zh) 1999-06-16
DE59507361D1 (de) 2000-01-13

Similar Documents

Publication Publication Date Title
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
FI972580A0 (fi) Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
PT734259E (pt) Utilizacao de derivados de piperidina para o tratamento da esquizofrenia
IT1205958B (it) Derivati di acido chinolincarbossilico e procedimento per la loro preparazione
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
DE69531476D1 (de) Serotonergische Modulatoren
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
ATE202704T1 (de) Verwendung eines natrium- oder lysiniumsalzes von crotonsäureamidderivaten zur herstellung eines arzneimittels zur behandlung von krebserkrankungen
FI952203A (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
IT1275997B1 (it) Enammine come accelleranti di vulcanizzazione per gomme naturali o sintetiche
DE69005984T2 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
KR880007070A (ko) 백내장 치료용 약학 조성물
BR9305752A (pt) Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
DE69232776D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenverbindungen in diesem Verfahren
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69232406D1 (de) Verfahren zur Herstellung von Fluoro-Chinolin-3-Carbonsäurederivate
DE69026991D1 (de) Phospholipide zur Behandlung der multiplen Sklerose

Legal Events

Date Code Title Description
MA Patent expired